相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Lipoprotein(a), venous thromboembolism and COVID-19: A pilot study
Nick S. Nurmohamed et al.
ATHEROSCLEROSIS (2022)
Current and novel biomarkers of thrombotic risk in COVID-19: a Consensus Statement from the International COVID-19 Thrombosis Biomarkers Colloquium
Diana A. Gorog et al.
NATURE REVIEWS CARDIOLOGY (2022)
Lipoprotein(a) and SARS-CoV-2 infections: Susceptibility to infections, ischemic heart disease and thromboembolic events
Silvia Di Maio et al.
JOURNAL OF INTERNAL MEDICINE (2022)
Thrombocytopathy and endotheliopathy: crucial contributors to COVID-19 thromboinflammation
Sean X. Gu et al.
NATURE REVIEWS CARDIOLOGY (2021)
Plasma tissue plasminogen activator and plasminogen activator inhibitor-1 in hospitalized COVID-19 patients
Yu Zuo et al.
SCIENTIFIC REPORTS (2021)
Genetic testing to restore the human right to identity in post-dictatorship Argentina: Ethical, legal, and social issues
Victor B. Penchaszadeh
AMERICAN JOURNAL OF MEDICAL GENETICS PART C-SEMINARS IN MEDICAL GENETICS (2021)
Biomarkers of coagulation, endothelial function, and fibrinolysis in critically ill patients with COVID-19: A single-center prospective longitudinal study
Ganeem K. Juneja et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Hypertriglyceridemia during hospitalization independently associates with mortality in patients with COVID-19
Wen Dai et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2021)
Platelets contribute to disease severity in COVID-19
Tessa J. Barrett et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2021)
Platelets amplify endotheliopathy in COVID-19
Tessa J. Barrett et al.
SCIENCE ADVANCES (2021)
Prevalence of Peripheral Vestibular Impairment in Adults with Human Immunodeficiency Virus
Alison Millar et al.
JOURNAL OF AUDIOLOGY AND OTOLOGY (2021)
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China
Dawei Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)
Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia
Ning Tang et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Chaolin Huang et al.
LANCET (2020)
Prominent changes in blood coagulation of patients with SARS-CoV-2 infection
Huan Han et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2020)
Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
Xiaobo Yang et al.
Lancet Respiratory Medicine (2020)
Clinical and immunological features of severe and moderate coronavirus disease 2019
Guang Chen et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Cardiac troponin I in patients with coronavirus disease 2019 (COVID-19): Evidence from a meta-analysis
Giuseppe Lippi et al.
PROGRESS IN CARDIOVASCULAR DISEASES (2020)
Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19
Yong Gao et al.
JOURNAL OF MEDICAL VIROLOGY (2020)
D-dimer is Associated with Severity of Coronavirus Disease 2019: A Pooled Analysis
Giuseppe Lippi et al.
THROMBOSIS AND HAEMOSTASIS (2020)
COVID-19 and Thrombotic or Thromboembolic Disease: Implications for Prevention, Antithrombotic Therapy, and Follow
Behnood Bikdeli et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China
Chaomin Wu et al.
JAMA INTERNAL MEDICINE (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Attention should be paid to venous thromboembolism prophylaxis in the management of COVID-19
Tao Wang et al.
LANCET HAEMATOLOGY (2020)
Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
Giuseppe Lippi et al.
CLINICA CHIMICA ACTA (2020)
Lipoprotein(a) and Its Potential Association with Thrombosis and Inflammation in COVID-19: a Testable Hypothesis
Patrick M. Moriarty et al.
CURRENT ATHEROSCLEROSIS REPORTS (2020)
Incidence of thrombotic complications in critically ill ICU patients with COVID-19
F. A. Klok et al.
THROMBOSIS RESEARCH (2020)
Pathophysiology of COVID-19-associated acute respiratory distress syndrome: a multicentre prospective observational study
Giacomo Grasselli et al.
LANCET RESPIRATORY MEDICINE (2020)
Risk of venous thromboembolism in patients with COVID-19: A systematic review and meta-analysis
Stephan Nopp et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Study of alteplase for respiratory failure in severe acute respiratory syndrome coronavirus 2/COVID-19: Study design of the phase IIa STARS trial
Hunter B. Moore et al.
RESEARCH AND PRACTICE IN THROMBOSIS AND HAEMOSTASIS (2020)
Elevated Lipoprotein(a) and Risk of Ischemic Stroke
Anne Langsted et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
An ATF6-tPA pathway in hepatocytes contributes to systemic fibrinolysis and is repressed by DACH1
Ze Zheng et al.
BLOOD (2019)
Thromboinflammation: challenges of therapeutically targeting coagulation and other host defense mechanisms
Shaun P. Jackson et al.
BLOOD (2019)
High levels of lipoprotein (a) and premature acute coronary syndrome
Loukianos S. Rallidis et al.
ATHEROSCLEROSIS (2018)
Elevated plasma lipoprotein(a) levels were associated with increased risk of cardiovascular events in Chinese patients with stable coronary artery disease
Wen Dai et al.
SCIENTIFIC REPORTS (2018)
A Test in Context: Lipoprotein(a) Diagnosis, Prognosis, Controversies, and Emerging Therapies
Sotirios Tsimikas
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Lipoprotein(a) as a Risk Factor for Venous Thromboembolism: A Systematic Review and Meta-analysis of the Literature
Francesco Dentali et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2017)
Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis
Danish Saleheen et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis-Brief Report
Mehdi Afshar et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2016)
Phenotypic Characterization of Genetically Lowered Human Lipoprotein(a) Levels
Connor A. Emdin et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Race Is a Key Variable in Assigning Lipoprotein(a) Cutoff Values for Coronary Heart Disease Risk Assessment The Multi-Ethnic Study of Atherosclerosis
Weihua Guan et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2015)
Lipoprotein (a) is a risk factor for coronary artery disease in Chinese Han ethnic population modified by some traditional risk factors: A cross-sectional study of 3462 cases and 6125 controls
Dong-Ping Cai et al.
CLINICA CHIMICA ACTA (2015)
Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State
Esteban Orenes-Pinero et al.
JOURNAL OF ATHEROSCLEROSIS AND THROMBOSIS (2015)
IL-6 blockade by monoclonal antibodies inhibits apolipoprotein (a) expression and lipoprotein (a) synthesis in humans
Nike Mueller et al.
JOURNAL OF LIPID RESEARCH (2015)
Myeloid-Derived Tissue-Type Plasminogen Activator Promotes Macrophage Motility through FAK, Rac1, and NF-κB Pathways
Ling Lin et al.
AMERICAN JOURNAL OF PATHOLOGY (2014)
Lipoprotein(a), polymorphisms in the LPA gene, and incident venous thromboembolism among 21 483 women
J. S. Danik et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
Genetic Evidence That Lipoprotein(a) Associates With Atherosclerotic Stenosis Rather Than Venous Thrombosis
Pia R. Kamstrup et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2012)
Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects The Atherosclerosis Risk in Communities (ARIC) Study
Salim S. Virani et al.
CIRCULATION (2012)
Apolipoprotein(a) Genetic Sequence Variants Associated With Systemic Atherosclerosis and Coronary Atherosclerotic Burden But Not With Venous Thromboembolism
Anna Helgadottir et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
The Thrombophilic Pattern of Different Clinical Manifestations of Venous Thromboembolism: A Survey of 443 Cases of Venous Thromboembolism
Elisa Grifoni et al.
SEMINARS IN THROMBOSIS AND HEMOSTASIS (2012)
Association of plasminogen activator inhibitor-1 and tissue plasminogen activator with type 2 diabetes and metabolic syndrome in Malaysian subjects
Zaid Al-Hamodi et al.
CARDIOVASCULAR DIABETOLOGY (2011)
Increased Stroke Risk and Lipoprotein(a) in a Multiethnic Community: The Northern Manhattan Stroke Study
Bernadette Boden-Albala et al.
CEREBROVASCULAR DISEASES (2010)
Comprehensive Analysis of Genomic Variation in the LPA Locus and Its Relationship to Plasma Lipoprotein(a) in South Asians, Chinese, and European Caucasians
Matthew B. Lanktree et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
Serum Lipoprotein (a) Levels in Patients with First Unprovoked Venous Thromboembolism is not Associated with Subsequent Risk of Recurrent VTE
M. A. Rodger et al.
THROMBOSIS RESEARCH (2010)
Relationship of Oxidized Phospholipids on Apolipoprotein B-100 Particles to Race/Ethnicity, Apolipoprotein(a) Isoform Size, and Cardiovascular Risk Factors Results From the Dallas Heart Study
Sotirios Tsimikas et al.
CIRCULATION (2009)
Genetically Elevated Lipoprotein(a) and Increased Risk of Myocardial Infarction
Pia R. Kamstrup et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Lipoprotein(a) Concentration and the Risk of Coronary Heart Disease, Stroke, and Nonvascular Mortality
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease
Robert Clarke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Role of fibrinolysis in obesity and thrombosis
H. R. Lijnen
THROMBOSIS RESEARCH (2009)
Lipoprotein(a) levels and risk of future coronary heart disease
Anna Bennet et al.
ARCHIVES OF INTERNAL MEDICINE (2008)
Association between lipoprotein(a) levels, apo(a) isoforms and family history of premature CAD in young Asian Indians
Jasvinder K. Gambhir et al.
CLINICAL BIOCHEMISTRY (2008)
Lipoprotein (a) and venous thromboembolism in adults: A meta-analysis
Francesco Sofi et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Lipoprotein(a) and incident ischemic stroke - The atherosclerosis risk in communities (ARIC) study
Tetsuya Ohira et al.
STROKE (2006)
Stimulated tissue plasminogen activator release as a marker of endothelial function in humans
JJ Oliver et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2005)
Tissue plasminogen activator antigen is strongly associated with myocardial infarction in young women
PM Mannucci et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2005)
The complex between tPA and PAI-1: risk factor for myocardial infarction as studied in the SHEEP project
A Nordenhem et al.
THROMBOSIS RESEARCH (2005)
High-dose atorvastatin reduces total plasma levels of oxidized phospholipids and immune complexes present on apolipoprotein B-100 in patients with acute coronary syndromes in the MIRACL trial
S Tsimikas et al.
CIRCULATION (2004)
Obesity and impaired fibrinolysis: role of adipose production of plasminogen activator inhibitor-1
T Skurk et al.
INTERNATIONAL JOURNAL OF OBESITY (2004)
4G/4G genotype of PAI-1 gene is associated with reduced risk of stroke in elderly
T Hoekstra et al.
STROKE (2003)
Inhibition of plasminogen activation by lipoprotein(a) - Critical domains in apolipoprotein(a) and mechanism of inhibition on fibrin and degraded fibrin surfaces
MA Hancock et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Intra-arterial tumor necrosis factor-α impairs endothelium-dependent vasodilatation and stimulates local tissue plasminogen activator release in humans
S Chia et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2003)
Temporal increases in plasma markers of oxidized low-density lipoprotein strongly reflect the presence of acute coronary syndromes
S Tsimikas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2003)
Cardiovascular risk factors and venous thromboembolism incidence - The longitudinal investigation of thromboembolism etiology
AW Tsai et al.
ARCHIVES OF INTERNAL MEDICINE (2002)